In particular, IGF-I receptor processing relies on this protease family, and so care must be taken to devise strategies for cleanly separating the actions of the PC family on ligand or receptor
This injectable medication targets both GLP-1 and GIP receptors, yielding the highest weight loss results among FDA-approved options
The global market for GLP-1 receptor agonists was valued at USD 53.46 billion in 2024 and is expected to grow to USD 156.71 billion by 2030 , reflecting a compound annual growth rate of 17.46% between 2025 and 2030
A dedicated Phase 3 liver disease trial for retatrutide is currently underway
Your system might get used to fish oil so you stop having episodes of diarrhea, but if you continue to experience loose, watery stools for more than a day or two, it's time to discuss alternative options with your healthcare professional, according to Mayo Clinic